HAL Id: hal-02616075
https://hal.univ-angers.fr/hal-02616075
Submitted on 24 May 2020
HAL is a multi-disciplinary open access archive for the deposit and dissemination of sci- entific research documents, whether they are pub- lished or not. The documents may come from teaching and research institutions in France or abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est destinée au dépôt et à la diffusion de documents scientifiques de niveau recherche, publiés ou non, émanant des établissements d’enseignement et de recherche français ou étrangers, des laboratoires publics ou privés.
Nanocarriers and nonviral methods for delivering antiangiogenic factors for glioblastoma therapy: the
story so far
Anne Clavreul, Milad Pourbaghi-Masouleh, Emilie Roger, Philippe Menei
To cite this version:
Anne Clavreul, Milad Pourbaghi-Masouleh, Emilie Roger, Philippe Menei. Nanocarriers and nonviral
methods for delivering antiangiogenic factors for glioblastoma therapy: the story so far. International
Journal of Nanomedicine, Dove Medical Press, 2019, 14, pp.2497-2513. �10.2147/IJN.S194858�. �hal-
02616075�
International Journal of Nanomedicine 2019:14 2497–2513
International Journal of Nanomedicine
This article was published in the following Dove Medical Press journal:
International Journal of Nanomedicine
Dovepress
submit your manuscript | www.dovepress.com
2497
R e v I e w
open access to scientific and medical research
Open Access Full Text Article
Nanocarriers and nonviral methods for delivering antiangiogenic factors for glioblastoma
therapy: the story so far
Anne Clavreul 1,2
Milad Pourbaghi-Masouleh 2,3 emilie Roger 4
Philippe Menei 1,2
1